MAQC

Massive Analysis and Quality Control Society

FDA/NCTR-MAQC 2022 Conference will occur Sept 26-27, 2022

(5th annual meeting of the MAQC Society)

U.S. FDA Headquarters, White Oak Conference Center, Silver Spring MD

The FDA/NCTR is a co-sponsor for the FDA/NCTR-MAQC 2022 Conference

Conference presentations, abstracts, and discussions will include themes around: Explainable/Reproducible AI/ML, AI/ML in health-related datasets, SARS-CoV-2 and public health, Sing-elcell, Genomics, image analysis, reference samples, reproducible science and more.

Click here to register

Nature Biotechnology Special Collection

Publications in Collection

Salit, M. & Woodcock, J. MAQC and the era of genomic medicine. Nat. Biotechnol. 1–2 (2021).
Xiao, W. et al. Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nat. Biotechnol. 1–10 (2021).
Fang, L. T. et al. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nat. Biotechnol. 1–10 (2021).
Chen, W. et al. A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples. Nat. Biotechnol. 1–12 (2020).
Deveson, I. W. et al. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat. Biotechnol. 1–14 (2021).
Foox, J. et al. Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study. Nat Biotechnol. 39, 1129–1140 (2021).
Chen, X. et al. A multi-center cross-platform single-cell RNA sequencing reference dataset. Sci. Data 8, 39 (2021).
Gong, B. et al. Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. Genome Biol. 22, 109 (2021).
Jones, W. et al. A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency. Genome Biol. 22, 111 (2021).
Zhang, L. et al. X-CNV: genome-wide prediction of the pathogenicity of copy number variations. Genome Med. 13, 132 (2021).

Membership

MAQC Society membership now open and offers many with exciting benefits.

Find out more or register now

MAQC

Massive Analysis and Quality Control Society

FDA/NCTR-MAQC 2022 Conference will occur Sept 26-27, 2022

(5th annual meeting of the MAQC Society)

U.S. FDA Headquarters, White Oak Conference Center, Silver Spring MD

The FDA/NCTR is a co-sponsor for the FDA/NCTR-MAQC 2022 Conference

Nature Biotechnology Special Collection

Publications in Collection

Salit, M. & Woodcock, J. MAQC and the era of genomic medicine. Nat. Biotechnol. 1–2 (2021).

Xiao, W. et al. Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nat. Biotechnol. 1–10 (2021).

Fang, L. T. et al. Establishing community reference samples, data and call sets for benchmarking cancer mutation detection using whole-genome sequencing. Nat. Biotechnol. 1–10 (2021).

Chen, W. et al. A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples. Nat. Biotechnol. 1–12 (2020).

Deveson, I. W. et al. Evaluating the analytical validity of circulating tumor DNA sequencing assays for precision oncology. Nat. Biotechnol. 1–14 (2021).

Foox, J. et al. Performance assessment of DNA sequencing platforms in the ABRF Next-Generation Sequencing Study. Nat Biotechnol. 39, 1129–1140 (2021).

Chen, X. et al. A multi-center cross-platform single-cell RNA sequencing reference dataset. Sci. Data 8, 39 (2021).

Gong, B. et al. Cross-oncopanel study reveals high sensitivity and accuracy with overall analytical performance depending on genomic regions. Genome Biol. 22, 109 (2021).

Jones, W. et al. A verified genomic reference sample for assessing performance of cancer panels detecting small variants of low allele frequency. Genome Biol. 22, 111 (2021).

Zhang, L. et al. X-CNV: genome-wide prediction of the pathogenicity of copy number variations. Genome Med. 13, 132 (2021).

Membership